Determination of Disinfectant Resistance Genes in Clinical Bacterial Isolates Klinik Bakteri İzolatlarında Dezenfektan Direnç Genlerinin Belirlenmesi
Adiyaman University Journal of Science, cilt.16, sa.1, ss.1-13, 2026 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 16 Sayı: 1
- Basım Tarihi: 2026
- Doi Numarası: 10.37094/adyujsci.1793461
- Dergi Adı: Adiyaman University Journal of Science
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.1-13
- Anahtar Kelimeler: Clinical isolates, Disinfectant, MICs, Resistance genes
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Hatay Mustafa Kemal Üniversitesi Adresli: Evet
Özet
In healthcare settings such as hospitals, bacteria develop resistance to disinfectants, which play a critical role in infection control, through various mechanisms. The presence and expression of efflux pumps are considered one of the key mechanisms of disinfectant resistance. The main objective of this study is to detect the presence of qacA/B, qacC/D, qacE, qacΔE1, qacG, qacH, qacJ, and acrA genes in clinical bacterial isolates and to determine the minimum inhibitory concentrations (MICs) against two different disinfectants: a quaternary ammonium compound and a biguanide. The presence of the related genes was screened in 40 clinical isolates using conventional polymerase chain reaction. Disinfectant susceptibility was determined by the agar dilution method. Species-level identification of the isolates was confirmed by Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) technique. As a result of the screening, 6 isolates (15%), confirmed as E. coli, K. pneumoniae, and P. aeruginosa, were found to possess the qacΔE1 gene. The MIC values for these isolates against benzalkonium chloride and chlorhexidine gluconate were found to be in the range of 32−256 mg/L and 2−16 mg/L, respectively. The findings revealed that there was no direct correlation between observed MIC values and the presence or absence of biocide resistance genes in the clinical E. coli, K. pneumoniae, and P. aeruginosa isolates studied.